Keyphrases
Aldehyde Oxidase
10%
Allosteric Modulator
17%
Asymmetric Allylic Alkylation
8%
Brevetoxin
10%
Carboxamide
13%
Cell-based
9%
Central Nervous System
12%
Chemotype
20%
CNS Exposure
8%
CNS Penetration
7%
Competitive Antagonist
7%
Disubstituted
9%
Enantioselective Synthesis
8%
Ether
13%
Fluoro
7%
Glutamate Receptors
9%
Glycolate
8%
Group II Metabotropic Glutamate Receptors
8%
High-throughput Screening
9%
Highly Selective
9%
Medium-sized Rings
11%
Metabotropic Glutamate Receptor
18%
Metabotropic Glutamate Receptor 5 (mGluR5)
69%
MGlu
28%
MGlu1
12%
MGlu2
12%
MGlu3
12%
MGlu5 NAM
15%
Mouse Model
12%
Negative Allosteric Modulator
95%
New Series
11%
Patent Review
10%
Penetrant
20%
Pharmacology
7%
Picolinamide
11%
Polo-like Kinase 1 (PLK1)
13%
Positive Allosteric Modulator
26%
Potassium Channel
17%
Potent Inhibitor
8%
Potential Therapeutics
8%
Relationship Research
10%
Ring-closing Metathesis
13%
Rodents
8%
Small Molecule Inhibitors
22%
Small Molecules
16%
Structure-activity Relationship
17%
Structure-activity Relationship Studies
8%
Thiophene
10%
Tool Compound
23%
Total Synthesis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Aldehyde Oxidase
10%
Allosteric Modulator
100%
Anxiolytic
5%
Benign Childhood Epilepsy
10%
Binding Site
7%
Carboxamide
14%
Clinical Trial
8%
Competitive Antagonist
10%
Cytochrome P450
6%
Disease
15%
Focal Epilepsy
13%
G Protein Coupled Receptor
7%
Glutamate Receptor
18%
High-Throughput Screening
5%
IC50
6%
Metabotropic Receptor
43%
Metabotropic Receptor 5
13%
Mouse Model
12%
Neuropeptide Y4 Receptor
6%
Parkinson's Disease
6%
Pharmacokinetics
12%
Picolinamide
8%
Polo Like Kinase 1
6%
Positive Allosteric Modulator
27%
Potassium Channel
22%
Protein Binding
11%
Pyrazine
5%
Receptor
22%
Somatomedin C Receptor
6%
Structure Activity Relationship
34%
Toxicology
5%
Xanthine
6%
